DNTH
Dianthus Therapeutics, Inc. · Healthcare
Fairmount Funds Management LLC bought $272K of Dianthus Therapeutics, Inc.
Director and 10% owner
Bought$271,680
$11.20Price
24,254Shares
+1%Stake
What DNTH did for a copier
- $1,000 copied at Thu, Sep 14 open, $12.25
- $947
- S&P 500, same days
- −7.8%
Measured over 30 trading days, to the Oct 26 close.
Fairmount Funds Management LLC's record
17 other buys with 3 months of prices since 2021: on average −7.5% against the S&P 500, and 6 of 17 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Sep 12. Filed Wed, Sep 13, 9:17 PM ET, after the close. Returns use the Sep 14 open and the Oct 26 close. Not investment advice.